PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
56.13
ESG score 90-95% of MDGL's 61.65. Bill Ackman would demand clear ESG improvement catalysts.
51.62
Environmental score 80-90% of MDGL's 62.49. Walter Schloss would scrutinize carbon exposure and transition planning.
57.46
Social score 90-95% of MDGL's 61.10. Bill Ackman would demand clear social improvement catalysts.
59.31
Similar governance score to MDGL's 61.37. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.